Viewing data from:

ALCLOMETASONE DIPROPIONATE

ANDA

ALCLOMETASONE DIPROPIONATE | A076730 | SUN PHARMA CANADA INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.9686

per gm

Lowest NADAC/Unit

$0.4926

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51672131601ALCLOMETASONE DIPR 0.05% OINT	$0.9686	GM	Generic	—	2026-06-17
51672131606ALCLOMETASONE DIPR 0.05% OINT	$0.5354	GM	Generic	—	2026-06-17
51672131603ALCLOMETASONE DIPR 0.05% OINT	$0.4926	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVALCLOMETASONE DIPROPIONATE

DMF 146922000

CURIA SPAIN SAUALCLOMETASONE DIPROPIONATE

DMF 168712003

NEWCHEM SPAALCLOMETASONE DIPROPIONATE MICRONIZED

DMF 433552026

SCHERING PHARMACEUTICAL CORPInactiveALCLOMETASONE DIPROPIONATE, USP

DMF 89441991

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jul 30, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.05%

0 patents0 exclusivities▴

OINTMENT;TOPICAL | Approved: Jul 29, 2004

No patent or exclusivity listings for this strength.